Wednesday, 2 April 2025
30.2 C
Singapore
35.1 C
Thailand
25.6 C
Indonesia
28.2 C
Philippines

Retro Biosciences, backed by Sam Altman, aims for US$1 billion to revolutionise ageing

Sam Altman backs Retro Biosciencesโ€™ US$1 billion raise to extend lifespan by 10 years, advance longevity technology, and target age-related diseases.

OpenAI CEO Sam Altman is ramping up his investment in Retro Biosciences, a San Francisco-based biotech company that aims to extend the healthy human lifespan by an additional 10 years. As reported by the Financial Times, the company is now raising US$1 billion in a Series A funding round, which Altman is supporting.

Building on a strong foundation

Altman had previously invested an impressive US$180 million in Retro Biosciencesโ€™ entire seed round. His continued backing reflects confidence in the companyโ€™s mission and potential. Retro Biosciences focuses on combating ageing-related diseases and advancing technologies to support longevity.

The startup has made significant strides in its research. Recently, it collaborated with OpenAI to train a model to transform ordinary cells into stem cells. These stem cells hold promise for treating various health conditions, including degenerative diseases like Alzheimerโ€™s.

Speaking to the Financial Times, Retro Biosciences CEO Joe Betts-LaCroix emphasised the urgency of their mission. He expressed a clear goal: to discover and develop a life-changing drug before the decade is over. “We want to move fast,” Betts-LaCroix said.

Billionaire-backed longevity movement

Retro Biosciences isnโ€™t alone in the race to extend human life. Several other billionaire-funded initiatives are working on similar goals. One of the most prominent examples is Altos Labs, launched in 2022 with US$3 billion in funding, backed by Amazon founder Jeff Bezos. Unity Biotechnology, another notable player in this space, has received support from Bezos and entrepreneur Peter Thiel.

These efforts highlight a growing interest in tackling the challenges of ageing and age-related diseases. The backing of tech visionaries and billionaires brings substantial financial resources and innovation to this emerging field.

With its ambitious goals and substantial financial support, Retro Biosciences is positioned as a key player in longevity. Its advancements in cell reprogramming and its determination to develop drugs targeting ageing-related diseases set it apart.

Altmanโ€™s financial commitment demonstrates his belief in the companyโ€™s vision and potential. As the biotech industry continues to explore groundbreaking ways to improve human health and extend life, Retro Biosciences will be watched to see if it can deliver on its promise to redefine healthy ageing in the years ahead.

Hot this week

Apple Intelligence now supports English (Singapore) with the latest update

Appleโ€™s latest update brings Apple Intelligence support for English (Singapore), making AI features more accessible without needing US English settings.

Fitbit users now have until 2026 to migrate to Google accounts

Fitbit users now have until February 2, 2026, to migrate their accounts to Google accounts or risk losing their data and service access.

Perplexity CEO dismisses financial concerns, confirms no IPO before 2028

Perplexity CEO Aravind Srinivas denies financial troubles, confirms the company has no plans for an IPO before 2028, and explains product changes.

Nothing Phone (3a) Pro review: A mid-range marvel with standout zoom

Nothing Phone (3a) Pro blends standout design, powerful zoom camera, and smart features, making it a top choice in the mid-range segment.

Owndays and Huawei launch new titanium smart audio glasses

Owndays and Huawei launch the Eyewear 2 Smart Audio Glasses Titanium Edition, featuring Bluetooth 5.3, 11-hour playback, and a premium frame.

Zelle is removing its stand-alone app

Zelle is shutting down its stand-alone app, but you can still use the service through your bankโ€™s app. Hereโ€™s what you need to know.

Apple may launch an AI-powered Health app with a coaching feature next year

Apple may introduce an AI-powered Health app with coaching, food tracking, and fitness guidance in 2026, possibly as a new subscription service.

These robot vacuums are getting smarter with Apple Home support

Appleโ€™s iOS 18.4 update adds Matter support for robot vacuums, enabling control via Apple Home. Roborock, iRobot, and Ecovacs are updating their devices.

Gmail introduces easier encryption for business emails

Google introduces a new encryption model for Gmail, making it easier for businesses to send secure emails without special software or certificates.

Related Articles